Zomedica Corp. (ZOMDF) stock

ZOMDFOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30

$0.08−0.00 (-0.55%)

Close on Oct 19, 2026Market cap $77.40MP/E –Yield –

Zomedica EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Zomedica has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ZOMDF.

Revenue growth31.3% · median 12.5%

Gross margin64.0% · median 82.3%

Operating margin-45.4% · median -114.1%

Net margin-41.4% · median -162.1%

Advertisement
300 × 250

See a number that looks wrong?